NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments
Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)(OTCQB: NMDBF)(FRA:6UF) announced Thursday a strategic partnership with BioScript Solutions, a Canadian leader in specialty care. Under the terms of the partnership, NeonMind and BioScript Solutions will leverage BioScript
